BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8011009)

  • 1. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
    Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
    Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.
    Macía MA; Frias J; Carcas AJ; Guerra P; Valiente R; Lucero ML
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):333-9. PubMed ID: 7582384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro dissolution and in vivo bioequivalence of two diclofenac enteric coated formulations.
    Basmenji S; Valizadeh H; Zakeri-Milani P
    Arzneimittelforschung; 2011; 61(10):566-70. PubMed ID: 22164964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
    Walter K; Weiss G; Laicher A; Stanislaus F
    Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
    Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
    J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
    Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
    Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.
    De Bernardi di Valserra M; Feletti F; Tripodi AS; Contos S; Carabelli A; Maggi L; Germogli R
    Arzneimittelforschung; 1993 Mar; 43(3):373-7. PubMed ID: 8489569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
    Lissy M; Stiff DD; Kowalski MM; Moore KA
    Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast.
    Schug BS; Brendel E; Wonnemann M; Wolf D; Wargenau M; Dingler A; Blume HH
    Eur J Clin Pharmacol; 2002 May; 58(2):119-25. PubMed ID: 12012144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of food on the absorption of diclofenac as a pure substance.
    Terhaag B; Gramatte T; Hrdlcka P; Richter K; Feller K
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):418-21. PubMed ID: 1748542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
    Raz I; Hussein Z; Samara E; Ben-David J
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of two verapamil formulations following repeated administration in steady-state conditions. An open, two-period, crossover study].
    Heintz B; Müller A; Lenhard G; Schütz M; Hutt HJ
    Arzneimittelforschung; 1996 Nov; 46(11):1060-3. PubMed ID: 9065315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.